• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Top Ships Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    2/14/23 2:26:03 PM ET
    $AMST
    $APTX
    $ATNX
    $BOXL
    Computer Software: Prepackaged Software
    Technology
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AMST alert in real time by email

    Gainers

    • Amesite Inc. (NASDAQ:AMST) shares jumped 123% to $0.6284 after the company announced GPT-3 powered functionality to its AI toolkit for customers and users.
    • Boxlight Corporation (NASDAQ:BOXL) gained 39% to $0.55. Boxlight authorized repurchase program of up to $15 million in shares of Class A common stock.
    • Blue Water Vaccines, Inc. (NASDAQ:BWV) shares rose 30.8% to $1.5299. Blue Water Vaccines recently appointed Frank Jaeger, seasoned commercial operations and business development executive, as Senior Vice President of Marketing and Business Development.
    • Iris Energy Limited (NASDAQ:IREN) gained 32% to $2.8199. Iris Energy said it is increasing its self-mining capacity from 2.0 EH/s to 5.5 EH/s.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) surged 24.2% to $0.2361.
    • Recruiter.com Group, Inc. (NASDAQ:RCRT) gained 20.1% to $0.4802 after the company announced a ChatGPT course and upskilling platform.
    • SkyWater Technology, Inc. (NASDAQ:SKYT) climbed 20.1% to $13.73 after the company posted better-than-expected Q4 results.
    • Fusion Pharmaceuticals Inc. (NASDAQ:FUSN) shares gained 19% to $4.32 after the company announced it will acquire the Phase 2 program for 225Ac-PSMA I&T, a radiopharmaceutical targeting metastatic castrate resistant prostate cancer.
    • United Insurance Holdings Corp. (NASDAQ:UIHC) jumped 17.3% to $1.29.
    • Palantir Technologies Inc. (NYSE:PLTR) rose 14.3% to $8.69 after the company reported better-than-expected fourth-quarter financial results. The company also issued first-quarter and FY23 guidance.
    • Genius Brands International, Inc. (NASDAQ:GNUS) shares gained 12.8% to $4.06 after the company announced an exclusive deal with BuzzFeed.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) surged 12.3% to $1.87.
    • Secoo Holding Limited (NASDAQ:SECO) gained 11.7% to $3.15.
    • Marathon Digital Holdings, Inc. (NASDAQ:MARA) surged 11.5% to $6.53.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) rose 11.3% to $0.8765.
    • Opendoor Technologies Inc. (NASDAQ:OPEN) gained 10% to $2.2100. Citigroup maintained Opendoor Technologies with a Neutral and raised the price target from $1.5 to $2.
    • Semantix, Inc. (NASDAQ:STIX) jumped 9.6% to $1.72.
    • Healthcare Triangle, Inc. (NASDAQ:HCTI) gained 9% to $ 0.2528.
    • Avis Budget Group, Inc. (NASDAQ:CAR) jumped 8.9% to $240.18 after the company reported better-than-expected fourth-quarter financial results.
    • Hyperfine, Inc. (NASDAQ:HYPR) gained 9% to $1.3400. Hyperfine announced FDA clearance for improved AI-powered software and expanded field of view for the swoop portable MR imaging system.

    Losers

    • Top Ships Inc. (NASDAQ:TOPS) shares dropped 44.8% to $0.91. TOP Ships priced $13.6 million registered direct offering at $1.35 per unit.
    • Mobiquity Technologies, Inc. (NASDAQ:MOBQ) dipped 30.7% to $0.3657. Mobiquity Technologies reported pricing of $3.75 million public offering.
    • IMV Inc. (NASDAQ:IMV) fell 27.8% to $0.9601. IMV announced preliminary data from the VITALIZE Phase 2B trial evaluating its lead DPX product, maveropepimut-S (MVP-S), in combination with Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) for relapsed, refractory Diffuse Large B Cell Lymphoma (r/r DLBCL).
    • Soligenix, Inc. (NASDAQ:SNGX) fell 27.4% to $4.2428 after the company announced it received a refusal to file letter from the FDA for its HyBryte new drug application in the treatment of cutaneous T-Cell lymphoma.
    • Sorrento Therapeutics, Inc. (NASDAQ:SRNE) declined 21.2% to $0.2028. Sorrento Therapeutics said its Scintilla Pharmaceuticals unit commenced voluntary proceedings under Chapter 11 of US bankruptcy code.
    • Cerberus Cyber Sentinel Corporation (NASDAQ:CISO) shares dropped 21.8% to $0.8601 after the company reported a proposed public offering of common stock.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) shares fell 21.4% to $75.65 after the company reported a proposed public offering and announced results upon completion of the U.S. clinical evaluation for the T2Biothreat Panel.
    • Shift Technologies, Inc. (NASDAQ:SFT) dipped 20.8% to $0.22.
    • Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) dropped 17.7% to $3.5117. HC Wainwright & Co. reiterated Corbus Pharmaceuticals with a Buy and maintained a $3 price target.
    • Aptinyx Inc. (NASDAQ:APTX) dropped 17.2% to $0.4606.
    • Endava plc (NYSE:DAVA) fell 14.3% to $75.65 after the company posted Q2 results.
    • China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) dropped 14.2% to $6.09. China Jo-Jo Drugstores announced a $2.625 million registered direct offering.
    • Titan Medical Inc. (NASDAQ:TMDI) fell 14% to $0.1635. Nasdaq notified Titan Medical regarding audit committee requirements.
    • Athenex, Inc. (NASDAQ:ATNX) dropped 13.5% to $0.1893.
    • VNET Group, Inc. (NASDAQ:VNET) shares fell 13.3% to $5.30.
    • The GEO Group, Inc. (NYSE:GEO) declined 12.5% to $10.45 after the company issued FY23 EPS guidance below estimates.
    • Cytek Biosciences, Inc. (NASDAQ:CTKB) dropped 12.5% to $11.38. DiaSorin's subsidiary Luminex Corporation will sell its Flow Cytometry & Imaging (FCI) business unit to Cytek Biosciences.
    • Tellurian Inc. (NYSE:TELL) fell 12% to $1.5750. B of A Securities downgraded Tellurian from Buy to Underperform and lowered the price target from $4 to $1.5.
    • Materialise NV (NASDAQ:MTLS) dropped 12% to $8.95 after the company posted a Q4 loss.
    • ContextLogic Inc. (NASDAQ:WISH) fell 10.8% to $0.7822.
    • MRC Global Inc. (NYSE:MRC) dropped 9.7% to $12.09 following weak quarterly sales.
    • Outset Medical, Inc. (NASDAQ:OM) fell 9.6% to $25.72 after the company reported Q4 results and issued FY23 guidance.
    • Guardforce AI Co., Limited (NASDAQ:GFAI) fell 7.8% to $14.29 after dropping 18% on Monday. Guardforce AI recently announced a 1-for-40 reverse split.
    • Edible Garden AG Incorporated (NASDAQ:EDBL) fell 7% to $3.83 after dropping around 8% on Monday. Edible Garden recently announced pricing of an upsized $10.2 million underwritten public offering.

    Now Read This: These 3 Utilities Stocks With Over 4% Dividend Yields Are Recommended By Benzinga's Most Accurate Analysts

    Get the next $AMST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMST
    $APTX
    $ATNX
    $BOXL

    CompanyDatePrice TargetRatingAnalyst
    Merck & Company Inc.
    $MRK
    2/25/2026$142.00Outperform
    RBC Capital Mkts
    Merck & Company Inc.
    $MRK
    2/20/2026$140.00Overweight
    Barclays
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Palantir Technologies Inc.
    $PLTR
    2/18/2026$195.00Neutral → Outperform
    Mizuho
    Merck & Company Inc.
    $MRK
    2/13/2026$150.00Hold → Buy
    Deutsche Bank
    Palantir Technologies Inc.
    $PLTR
    2/10/2026$180.00Neutral → Buy
    Daiwa Securities
    MARA Holdings Inc.
    $MARA
    2/9/2026$8.00Underweight
    Morgan Stanley
    Palantir Technologies Inc.
    $PLTR
    2/3/2026$205.00Hold → Buy
    HSBC Securities
    More analyst ratings

    $AMST
    $APTX
    $ATNX
    $BOXL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Merck with a new price target

    RBC Capital Mkts initiated coverage of Merck with a rating of Outperform and set a new price target of $142.00

    2/25/26 7:52:46 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Barclays initiated coverage on Merck with a new price target

    Barclays initiated coverage of Merck with a rating of Overweight and set a new price target of $140.00

    2/20/26 8:25:04 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    GeoVax Labs downgraded by D. Boral Capital

    D. Boral Capital downgraded GeoVax Labs from Buy to Hold

    2/19/26 8:44:06 AM ET
    $GOVX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMST
    $APTX
    $ATNX
    $BOXL
    SEC Filings

    View All

    MARA Holdings Inc. filed SEC Form 8-K: Leadership Update

    8-K - MARA Holdings, Inc. (0001507605) (Filer)

    2/25/26 5:00:28 PM ET
    $MARA
    EDP Services
    Technology

    SEC Form 10-K filed by Geo Group Inc REIT

    10-K - GEO GROUP INC (0000923796) (Filer)

    2/25/26 4:30:11 PM ET
    $GEO
    Homebuilding
    Consumer Discretionary

    SEC Form 425 filed by SkyWater Technology Inc.

    425 - SkyWater Technology, Inc (0001819974) (Subject)

    2/25/26 4:16:36 PM ET
    $SKYT
    Semiconductors
    Technology

    $AMST
    $APTX
    $ATNX
    $BOXL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Guardforce AI Announces Extension of Smart Retail Solutions Partnership with Major Global Sportswear Brand

    NEW YORK, NY, Feb. 26, 2026 (GLOBE NEWSWIRE) --   Guardforce AI Co., Limited ("Guardforce AI" or the "Company") (NASDAQ:GFAI, GFAIW)), an AI-driven technology company providing Agentic AI smart solutions in automation, robotics, and secured logistics, today announced the extension of its partnership to provide smart retail business solutions to the Thailand branch of a renowned global sportswear brand. Under the extended partnership, Guardforce AI acts as an important technology partner in the client's ongoing national renovation plan. The Company has received the first batch of requests to deploy its smart retail solutions at five additional retail locations in 2026, and one more install

    2/26/26 8:30:00 AM ET
    $GFAI
    Diversified Commercial Services
    Consumer Discretionary

    Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease

    PRINCETON, N.J., Feb. 26, 2026 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) provided a positive recommendation on the Company's request for orphan drug designation for dusquetide (the active pharmaceutical ingredient in SGX945) for the treatment of Behçet's Disease, following review of the recently published Phase 2a clinical results demonstrating biological efficacy and safety in patients with Behçet's Disease.

    2/26/26 7:30:00 AM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approves NUMELVI™ (atinvicitinib tablets) for Dogs from Merck Animal Health – The First and Only Second-Generation Janus Kinase (JAK) Inhibitor for the Control of Pruritus Associated with Allergic Dermatitis

    The only JAK inhibitor approved in the U.S. for the control of pruritus associated with allergic dermatitis in dogs six months of age and older Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today the U.S. Food and Drug Administration (FDA) approval of NUMELVI™ (atinvicitinib tablets) – the first and only second-generation Janus kinase (JAK) inhibitor indicated for the control of pruritus associated with allergic dermatitis in dogs six months of age and older. The product is expected to be available at veterinary clinics and hospitals nationwide in spring 2026. "Merck Anima

    2/25/26 4:30:00 PM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMST
    $APTX
    $ATNX
    $BOXL
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for FAMOTIDINE issued to ATHENEX INC

    Submission status for ATHENEX INC's drug FAMOTIDINE (SUPPL-13) with active ingredient FAMOTIDINE has changed to 'Approval' on 01/07/2022. Application Category: ANDA, Application Number: 075684, Application Classification: Labeling

    1/12/22 4:41:30 AM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for KLISYRI

    Submission status for ATHENEX INC's drug KLISYRI (ORIG-1) with active ingredient TIRBANIBULIN has changed to 'Approval' on 12/14/2020. Application Category: NDA, Application Number: 213189, Application Classification: Type 1 - New Molecular Entity

    12/20/20 4:30:55 PM ET
    $ATNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMST
    $APTX
    $ATNX
    $BOXL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Pentwater Capital Management Lp bought $40,060,075 worth of shares (425,000 units at $94.26) and exercised 85,200 in-the-money shares at a strike of $130.46 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:40:48 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    New insider Pentwater Capital Management Lp claimed ownership of 3,562,100 shares (SEC Form 3)

    3 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:37:08 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    Chief Executive Officer Thiel Frederick G covered exercise/tax liability with 91,356 shares, decreasing direct ownership by 2% to 4,816,459 units (SEC Form 4)

    4 - MARA Holdings, Inc. (0001507605) (Issuer)

    2/24/26 9:00:05 PM ET
    $MARA
    EDP Services
    Technology

    $AMST
    $APTX
    $ATNX
    $BOXL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Pentwater Capital Management Lp bought $40,060,075 worth of shares (425,000 units at $94.26) and exercised 85,200 in-the-money shares at a strike of $130.46 (SEC Form 4)

    4 - AVIS BUDGET GROUP, INC. (0000723612) (Issuer)

    2/24/26 9:40:48 PM ET
    $CAR
    Rental/Leasing Companies
    Consumer Discretionary

    President and CEO Kras James E. bought $2,050 worth of shares (3,700 units at $0.55), increasing direct ownership by 102% to 7,317 units (SEC Form 4)

    4 - Edible Garden AG Inc (0001809750) (Issuer)

    1/5/26 8:51:35 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    Chief Executive Officer Nejatian Kasra bought $1,004,562 worth of shares (125,000 units at $8.04), increasing direct ownership by 0.15% to 83,478,299 units (SEC Form 4)

    4 - Opendoor Technologies Inc. (0001801169) (Issuer)

    11/12/25 8:27:43 AM ET
    $OPEN
    Real Estate
    Finance

    $AMST
    $APTX
    $ATNX
    $BOXL
    Financials

    Live finance-specific insights

    View All

    MARA Schedules Conference Call for Fourth Quarter and Fiscal Year 2025 Financial Results

    Earnings Webcast and Conference Call Set for Thursday, February 26, 2026 at 5:00 p.m. ET Miami, FL, Feb. 20, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a leading digital energy and infrastructure company, will hold a webcast and conference call on Thursday, February 26, 2026 at 5:00 p.m. Eastern time to discuss its financial results for the quarter and fiscal year ended December 31, 2025. Financial results will be published in a shareholder letter prior to the call on the investor relations section of the Company's website. To register to participate in the conference call or to listen to the live audio webcast, please use this link. The webcas

    2/20/26 8:05:00 AM ET
    $MARA
    EDP Services
    Technology

    Q4 2025 Open House: Opendoor 2.0 Does What It Said It Would Do — Delivering Acquisition Growth, Faster Inventory Turns, and Stronger Cohorts

    SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (NASDAQ:OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for its fourth quarter and year ended December 31, 2025. "Last quarter, we outlined a four-step plan to transform Opendoor: reach breakeven Adjusted Net Income by the end of 2026 on a 12-month go-forward basis, drive positive unit economics while increasing transaction velocity, transition to direct-to-consumer relationships, and expand our product suite. This quarter demonstrates we are executing on that plan," said Kaz Nejatian, CEO of Opendoor. "These results reflect structural improvements in

    2/19/26 4:05:00 PM ET
    $OPEN
    Real Estate
    Finance

    Endava Announces Second Quarter Fiscal Year 2026 Results

    Q2 FY2026 5.9% Year on Year Revenue Decline to £184.1 million 5.1% Revenue Decline at Constant Currency Diluted EPS £(0.13) compared to £0.11 in the prior year comparative period Adjusted Diluted EPS £0.16 compared to £0.30 in the prior year comparative period Endava plc (NYSE:DAVA) ("Endava" or the "Company"), the technology-driven business transformation group whose AI-native approach combines cutting edge technology with deep industry expertise, today announced results for the three months ended December 31, 2025 ("Q2 FY2026"). "Over the past several quarters we have been investing heavily in our pivot towards AI to establish Endava as an AI leader. These investments have encompassed

    2/19/26 7:15:00 AM ET
    $DAVA
    EDP Services
    Technology

    $AMST
    $APTX
    $ATNX
    $BOXL
    Leadership Updates

    Live Leadership Updates

    View All

    CISO Global Appoints Dhaval Damania as EVP of Cybersecurity & IT

    Experienced AI and enterprise IT operations leader joins Company to accelerate scalable growth, strengthen security architecture, and advance next-generation cyber software innovation Scottsdale, Ariz., Feb. 23, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Dhaval Damania as Executive Vice President of Cybersecurity & IT. This appointment reinforces its continued commitment to operational excellence, innovation, and scalable growth across its next-generation cybersecurity software portfolio. In this role, Damania will lead CISO Global's

    2/23/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    Merck Evolves Human Health Operating Structure to Support Portfolio Execution

    Merck (NYSE:MRK), known as MSD outside of the United States and Canada, today highlighted steps to evolve the structure of its Human Health organization to ensure strong commercial execution of launches across diverse therapeutic areas, positioning the company for continued commercial success. As part of this evolution, Merck is organizing its Human Health business into an Oncology Business Unit and a Specialty, Pharma & Infectious Diseases Business Unit. This structure will enable Merck to sustain long-term leadership in oncology, while maintaining a sharp focus in support of a growing number of launches across an increasingly broad and diverse portfolio. In support of the new Human He

    2/23/26 6:45:00 AM ET
    $MRK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CISO Global Lands 30 Year Sales Veteran Michael Czerneda to Ignite the Next Wave of Software Growth

    New Vice President of Sales to accelerate software-driven growth across cyber services platform and insurance distribution channels  Scottsdale, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ:CISO) ("CISO Global" or the "Company"), a provider of AI-powered cybersecurity software and compliance services, today announced the appointment of Michael Czerneda as Vice President of Sales. In this role, Czerneda will lead enterprise-wide sales initiatives as the Company accelerates its transition toward scalable, software-driven growth built on its established cyber services platform.  Czerneda brings more than 30 years of sales leadership experience spanning UCaaS, CCaaS, da

    2/18/26 8:30:00 AM ET
    $CISO
    Professional Services
    Consumer Discretionary

    $AMST
    $APTX
    $ATNX
    $BOXL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Mobiquity Technologies Inc.

    SC 13G/A - Mobiquity Technologies, Inc. (0001084267) (Subject)

    11/20/24 7:44:24 PM ET
    $MOBQ
    Advertising
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Corbus Pharmaceuticals Holdings Inc.

    SC 13G/A - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Subject)

    11/14/24 7:48:14 PM ET
    $CRBP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Edible Garden AG Incorporated

    SC 13G/A - Edible Garden AG Inc (0001809750) (Subject)

    11/14/24 7:24:20 PM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples